Randomised phase 2 study of pembrolizumab plus CC-486 versus pembrolizumab plus placebo in patients with previously treated advanced non-small cell lung cancer
Titel:
Randomised phase 2 study of pembrolizumab plus CC-486 versus pembrolizumab plus placebo in patients with previously treated advanced non-small cell lung cancer
Auteur:
Levy, Benjamin P. Giaccone, Giuseppe Besse, Benjamin Felip, Enriqueta Garassino, Marina Chiara Domine Gomez, Manuel Garrido, Pilar Piperdi, Bilal Ponce-Aix, Santiago Menezes, Daniel MacBeth, Kyle J. RisueƱo, Alberto Slepetis, Ruta Wu, Xiaoling Fandi, Abderrahim Paz-Ares, Luis